Lexaria Bioscience Taps Harvard Medical Expert to Accelerate GLP-1 & Hypertension Drug Development

Leading Harvard cardiologist Dr. Michael Gibson joins Lexaria as Chief Medical Advisor, bringing expertise in FDA submissions to advance...
1 day ago
from: Stock Titan

Harvard Medical School, Medicine, NASDAQ:LEXX

More about this

- Lexaria forms scientific advisory board to enhance drug delivery tech
KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), a $36.3 million market cap biotech company known for its drug delivery...
from: Investing.com

- Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
Dr. Gibson joining Lexaria's new scientific advisor board. KELOWNA, BC / ACCESSWIRE / December 17, 2024 / Lexaria Bioscience Corp.
from: www.yourcentralvalley.com

- Lexaria Bioscience forms Scientific Advisory Board
Lexaria Bioscience (LEXX) announces the creation of its new Scientific Advisory Board to assist in guiding Lexaria's rapid drug delivery...
from: TipRanks

- Lexaria Bioscience Bolsters Drug Delivery Strategy
Lexaria Bioscience formed a Scientific Advisory Board to enhance its drug delivery platform. The board aims to guide Lexaria's strategic...
from: TipRanks

- Lexaria Bioscience Forms Elite Scientific Advisory Board with Harvard Medical School Expert
Lexaria Bioscience Corp. (Nasdaq:LEXX) has announced the formation of a new Scientific Advisory Board (SAB) to guide its drug delivery...
from: Stock Titan

- Lexaria Forms New Scientific Advisory Board
North American drug delivery development experts added to help guide Lexaria's strategic plans. KELOWNA, BC / ACCESSWIRE / December 18,...
from: cbs4indy.com

- Lexaria Bioscience Welcomes New Chief Medical Advisor
Lexaria Bioscience (LEXX) has released an update. Pick the best stocks and maximize your portfolio: Discover top-rated stocks from highly...
from: TipRanks

- Lexaria Forms New Scientific Advisory Board
North American drug delivery development experts added to help guide Lexaria's strategic plans KELOWNA, BC / ACCESSWIRE / December 18,...
from: Yahoo Finance

- Lexaria Bioscience appoints Michael Gibson as chief medical advisor
Lexaria Bioscience (LEXX) announces the appointment of Dr. Michael Gibson as its new Chief Medical Advisor. Dr. Gibson will collaborate...
from: TipRanks